a procedureCochlear implant

An electronic device that bypasses the damaged inner ear and stimulates the hearing nerve directly. The US National Institute on Deafness and Other Communication Disorders describes four parts: a microphone, a speech processor, "a transmitter and receiver/stimulator, which receive signals from the speech processor and convert them into electric impulses", and "an electrode array, which is a group of electrodes that collects the impulses from the stimulator and sends them to different regions of the auditory nerve". The receiver-stimulator and the array are surgical and permanent. The microphone and processor are worn, replaceable, and priced separately. As of December 2019 the institute counts "approximately 736,900 registered devices" implanted worldwide.

The operation travels easily. The aftercare does not, and this is the clearest case in the directory of an operation whose price is the smaller half of the transaction.

Nothing about implantation itself resists being sold as a package: a couple of hours under general anaesthetic, a short stay, a wound that heals. What follows does resist. The device is switched on weeks after surgery, not in theatre, and is then programmed repeatedly — often, at first, and then for life. The institute puts the demand plainly: "use of a cochlear implant requires both a surgical procedure and significant therapy to learn or relearn the sense of hearing", with speech-language pathologists and audiologists involved throughout. A Finnish cost-effectiveness study published in 2025 says the same from the payer's side: an implant "requires life-long aftercare including regular check-ups, software and sound processor upgrades and sometimes a device replacement".

The processor is the trap inside the trap. Its warranty runs three years. Its modelled mean life before upgrade is 106 months — about nine years, on a range of 29 to 232 — sourced in that Finnish model to a manufacturer's own database. And when a model goes out of production the problem is not fashion: "access to spare parts is reduced for obsolete sound processors that are no longer manufactured, reducing the ability to service and repair sound processors, leaving recipients without a functioning CI system and no functional hearing". An implanted ear with a dead processor is a deaf ear.

Australia has measured what that costs. The CUSP study upgraded 340 processors in 304 adults aged 65 and over between May 2021 and April 2023, all of them with obsolete processors and no funding to replace them; its authors describe the position as "an increasing public health challenge in Australia and worldwide", and found the economic value of upgrading came "from preventing device failures, rather than from access to newer technology features".

Inference — every one of those facts lands harder on a patient implanted in another country. Programming is done by an audiologist on the manufacturer's software with the patient's own map; a clinic at home that never implanted the device may not hold the map, may not stock the parts, and may not take the patient on.

General anaesthesia; the array is threaded into the cochlea and the receiver seated in a well drilled in the bone behind the ear. Trade practice — the operation runs a couple of hours and is commonly a day case or a single night, and the two ears are sometimes done in one sitting. Switch-on comes weeks later, once the wound has settled, and is followed by a run of mapping appointments — frequent in the first year, then periodic for life. Rehabilitation is the long part: the brain has to learn to read the signal. The published failure figures are for the internal device: a Finnish model uses a 2.8% probability of internal device failure, an Australian model 4.8% over thirty years, with reimplantation — another operation — costed at 39,519 Australian dollars.

The published prices that matter here are for the parts, not the operation. At the time of the Australian CUSP study the out-of-pocket cost of a replacement processor was 7,648 Australian dollars for a Nucleus 5, 8,114 for a Kanso 2 and 9,078 for a Nucleus 7, which the authors say "limits CI users' ability to upgrade sound processors without public subsidy". The Finnish model puts the whole lifetime cost of a unilateral implant, care included, at 43,905 euros. No hospital price list for implantation for a self-paying foreign patient was read for this record on 16 September 2026.

This page describes a device and what maintaining it involves. It is not advice about whether to have one, or where.